跳至主要内容
临床试验/CTRI/2024/09/074272
CTRI/2024/09/074272尚未招募不适用

Comparative Study of the Efficacy of Intravenous Ondansetron Versus Intravenous Palonosetron in the Prevention of Postoperative Nausea and Vomiting in Elective Laparoscopic Surgeries

Gulbarga institute of medical sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年12月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To compare the efficacy of ondansetron and palonosetron in reducing the incidence of postoperative nausea and vomiting.

研究概览

简要总结

This study is mainly aiming to study the efficacy of two different drugs. Here ondansetron is already an established drug where palonosetron in newly introduced in use for postoperative nausea and vomiting in all laparoscopic surgeries.

Hope this study is helpful in knowing efficacy of palonosetron.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • American society of Anesthesiologists (ASA) grade I and II Patients giving informed written valid consent.
  • Either sex.
  • Patients scheduled to undergo elective laparoscopic surgeries.

排除标准

  • History of allergy to Ondansetron or Palonosetron.
  • Patients posted for emergency surgery.
  • Pregnant History of nausea and vomiting 24hrs prior to surgery.
  • History of motion sickness.

结局指标

主要结局

To compare the efficacy of ondansetron and palonosetron in reducing the incidence of postoperative nausea and vomiting.

时间窗: To compare the efficacy of ondansetron and palonosetron on the incidence of postoperative nausea and vomiting, the postoperative periods of 0-2 hours, 2-6 hours, and 6-24 hours should be considered.

次要结局

  • To examine hemodynamic parameters & adverse effects in both groups.(0-2 hours, 2-6hours, 6-24hours postoperative period.)

研究者

发起方
Gulbarga institute of medical sciences
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Sumangala Mulagund

Gulbarga institute of medical sciences

研究点 (1)

Loading locations...

相似试验